Mark Fereshteh
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- HER2/EGFR in Cancer Research 2
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Tannishtha Reya (3 shared papers)Philip A. Beachy (2 shared papers)Hyog Young Kwon (2 shared papers)John P. Chute (1 shared paper)Catriona H. M. Jamieson (1 shared paper)Michael J. Munchhof (1 shared paper)Annelie E. Abrahamsson (1 shared paper)David Alan Rizzieri (1 shared paper)
- Journals
- ACS Medicinal Chemistry Letters (6 papers)SLAS DISCOVERY (3 papers)Journal for ImmunoTherapy of Cancer (2 papers)PLoS ONE (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Mark Fereshteh
24 papers receiving 1.8k citations
Mark Fereshteh's Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 289
- Oncology 403
- Molecular Biology 732
- Biological Psychiatry 9
- Cancer Research 86
Countries citing papers authored by Mark Fereshteh
This map shows the geographic impact of Mark Fereshteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fereshteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fereshteh more than expected).
Fields of papers citing papers by Mark Fereshteh
This network shows the impact of papers produced by Mark Fereshteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fereshteh. The network helps show where Mark Fereshteh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Fereshteh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia Hit paper breakdown → | 2009 | 724 |
| 2 | 2010 | 446 | |
| 3 | 2022 | 101 | |
| 4 | 2008 | 87 | |
| 5 | 2007 | 57 | |
| 6 | 2019 | 53 | |
| 7 | 2012 | 52 | |
| 8 | 2008 | 48 | |
| 9 | 2014 | 44 | |
| 10 | 2015 | 37 | |
| 11 | 2022 | 36 | |
| 12 | 2018 | 34 | |
| 13 | 2018 | 28 | |
| 14 | 2022 | 27 | |
| 15 | 2020 | 26 | |
| 16 | 2021 | 24 | |
| 17 | 2001 | 21 | |
| 18 | 2025 | 12 | |
| 19 | 2020 | 11 | |
| 20 | 2021 | 11 |
About Mark Fereshteh
Mark Fereshteh is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Organic Chemistry, having authored 25 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), TGF-β signaling in diseases (3 papers), Synthesis and biological activity (3 papers), Immunotherapy and Immune Responses (3 papers), Hedgehog Signaling Pathway Studies (2 papers), HER2/EGFR in Cancer Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Hematology (289 citations), Oncology (403 citations), Molecular Biology (732 citations), Biological Psychiatry (9 citations) and Cancer Research (86 citations). Mark Fereshteh has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Tannishtha Reya, Philip A. Beachy, Hyog Young Kwon, John P. Chute, Catriona H. M. Jamieson, Michael J. Munchhof, Annelie E. Abrahamsson, David Alan Rizzieri, Jordan M. Blum and Todd L. VanArsdale. Their work appears in journals such as ACS Medicinal Chemistry Letters, SLAS DISCOVERY, Journal for ImmunoTherapy of Cancer, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.